Impact BioMedical announces 1-for-12.62 reverse stock split ahead of merger

September 11, 2026 4:05 PM

Impact BioMedical Inc. (NYSE American: IBO) announced that its board of directors has approved a 1-for-12.62 reverse stock split of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found